Zhejiang Orient Gene Biotech Balance Sheet Health
Financial Health criteria checks 4/6
Zhejiang Orient Gene Biotech has a total shareholder equity of CN¥7.2B and total debt of CN¥536.0M, which brings its debt-to-equity ratio to 7.5%. Its total assets and total liabilities are CN¥8.4B and CN¥1.3B respectively.
Key information
7.5%
Debt to equity ratio
CN¥535.98m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥3.95b |
| Equity | CN¥7.19b |
| Total liabilities | CN¥1.26b |
| Total assets | CN¥8.44b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688298's short term assets (CN¥4.8B) exceed its short term liabilities (CN¥1.2B).
Long Term Liabilities: 688298's short term assets (CN¥4.8B) exceed its long term liabilities (CN¥69.6M).
Debt to Equity History and Analysis
Debt Level: 688298 has more cash than its total debt.
Reducing Debt: 688298's debt to equity ratio has reduced from 13.6% to 7.5% over the past 5 years.
Debt Coverage: 688298's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 688298's interest payments on its debt are well covered by EBIT.